Skip to content

Clinical trials

Completed Phase 4 Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Phase 4 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20073
20081
20103
20111
20122
20131
20151
20213
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Novartis2
Vista Klinik2
Brandon G. Busbee, MD1
Kim's Eye Hospital1
Oklahoma State University Center for Health Sciences1
Pusan National University Hospital1
Retina Research Institute, LLC1
Retinal Consultants of Arizona1
University of Melbourne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization18
Macular Degeneration13
Vision Disorders4
Wet Macular Degeneration4
Geographic Atrophy3
Eye Diseases2
Macular Edema2
Retinal Degeneration2
Retinal Diseases2
Retinal Vein Occlusion2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.